Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
D000328:Adult; D001500:BCG Vaccine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007104:Immune Adherence Reaction; D008213:Lymphocyte Activation; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors; D014165:Transfer Factor / Q000627:therapeutic use*
D001500:BCG Vaccine; D008263:Macrophage Migration-Inhibitory Factors; D014165:Transfer Factor